Association Between Early Recovery of Renal Function and Residual Renal Function After Robot-assisted Partial Nephrectomy.

IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
In vivo Pub Date : 2025-05-01 DOI:10.21873/invivo.13955
Shunta Hori, Mitsuru Tomizawa, Kenta Onishi, Yosuke Morizawa, Daisuke Gotoh, Tomonori Nakahama, Yasushi Nakai, Makito Miyake, Tatsuo Yoneda, Nobumichi Tanaka, Kiyohide Fujimoto
{"title":"Association Between Early Recovery of Renal Function and Residual Renal Function After Robot-assisted Partial Nephrectomy.","authors":"Shunta Hori, Mitsuru Tomizawa, Kenta Onishi, Yosuke Morizawa, Daisuke Gotoh, Tomonori Nakahama, Yasushi Nakai, Makito Miyake, Tatsuo Yoneda, Nobumichi Tanaka, Kiyohide Fujimoto","doi":"10.21873/invivo.13955","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>This study aimed to explore factors related to residual renal function in patients with small renal tumors treated with robot-assisted partial nephrectomy.</p><p><strong>Patients and methods: </strong>This retrospective study included 188 patients with two functioning kidneys who were diagnosed with localized renal tumors and underwent robot-assisted partial nephrectomy using the clamping technique. The residual renal function 12 months after the surgery was evaluated in two ways: >90% preservation of the estimated glomerular filtration rate and no stage progression of chronic kidney disease.</p><p><strong>Results: </strong>The median age, body mass index, and warm ischemic time were 68 years, 23.3 kg/m<sup>2</sup>, and 19 min, respectively. Ten patients were diagnosed with positive surgical margins. Multivariate analysis revealed no significant preoperative factors, including renal function. Among surgical factors, warm ischemic time was an independent factor for chronic kidney disease progression, whereas it showed no significant association with the preservation of residual renal function (<i>p</i> =0.042 and p=0.14, respectively). Early recovery, defined as the difference in estimated glomerular filtration rate before and three months post-surgery, independently correlated with poor residual renal function preservation and chronic kidney disease progression (<i>p</i><0.0001 and <i>p</i><0.0001, respectively). Furthermore, no significant difference was observed in residual renal function recovery between warm ischemic time <25 and ≥25 min (<i>p</i>=0.58).</p><p><strong>Conclusion: </strong>Early recovery from residual renal function was crucial for preserving residual renal function and preventing chronic kidney disease progression after surgery. Understanding the factors influencing residual renal function preservation might lead to the optimization of treatment strategies in current clinical practice.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"39 3","pages":"1554-1566"},"PeriodicalIF":1.8000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12041977/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"In vivo","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/invivo.13955","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background/aim: This study aimed to explore factors related to residual renal function in patients with small renal tumors treated with robot-assisted partial nephrectomy.

Patients and methods: This retrospective study included 188 patients with two functioning kidneys who were diagnosed with localized renal tumors and underwent robot-assisted partial nephrectomy using the clamping technique. The residual renal function 12 months after the surgery was evaluated in two ways: >90% preservation of the estimated glomerular filtration rate and no stage progression of chronic kidney disease.

Results: The median age, body mass index, and warm ischemic time were 68 years, 23.3 kg/m2, and 19 min, respectively. Ten patients were diagnosed with positive surgical margins. Multivariate analysis revealed no significant preoperative factors, including renal function. Among surgical factors, warm ischemic time was an independent factor for chronic kidney disease progression, whereas it showed no significant association with the preservation of residual renal function (p =0.042 and p=0.14, respectively). Early recovery, defined as the difference in estimated glomerular filtration rate before and three months post-surgery, independently correlated with poor residual renal function preservation and chronic kidney disease progression (p<0.0001 and p<0.0001, respectively). Furthermore, no significant difference was observed in residual renal function recovery between warm ischemic time <25 and ≥25 min (p=0.58).

Conclusion: Early recovery from residual renal function was crucial for preserving residual renal function and preventing chronic kidney disease progression after surgery. Understanding the factors influencing residual renal function preservation might lead to the optimization of treatment strategies in current clinical practice.

机器人辅助部分肾切除术后早期肾功能恢复与残余肾功能的关系。
背景/目的:本研究旨在探讨机器人辅助肾部分切除术后小肾肿瘤患者残留肾功能的相关因素。患者和方法:本回顾性研究纳入188例双肾功能正常的患者,这些患者被诊断为局部肾肿瘤,并采用机器人辅助的夹持技术进行部分肾切除术。术后12个月的残余肾功能以两种方式评估:肾小球滤过率保留率为>90%,慢性肾脏疾病无分期进展。结果:年龄中位数68岁,体质量指数中位数23.3 kg/m2,热缺血时间中位数19 min。10例患者被诊断为手术切缘阳性。多因素分析显示术前无明显因素,包括肾功能。在手术因素中,热缺血时间是慢性肾脏疾病进展的独立因素,而与残余肾功能的保存无显著相关性(p =0.042和p=0.14)。早期恢复,定义为术前和术后3个月肾小球滤过率估计值的差异,与残余肾功能保存不良和慢性肾脏疾病进展独立相关(ppp=0.58)。结论:术后早期恢复对保留肾功能和预防慢性肾脏疾病进展至关重要。了解影响残余肾功能保存的因素可能有助于优化当前临床实践中的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
In vivo
In vivo 医学-医学:研究与实验
CiteScore
4.20
自引率
4.30%
发文量
330
审稿时长
3-8 weeks
期刊介绍: IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management. The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信